Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth In/near Infected Bone Cavities
Not Applicable
Recruiting
- Conditions
- Periprosthetic Joint Infections
- First Posted Date
- 2022-05-05
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Elute, Inc.
- Target Recruit Count
- 204
- Registration Number
- NCT05361941
- Locations
- 🇺🇸
Endeavor Health Skokie Hospital, Skokie, Illinois, United States
🇺🇸U Michigan Medical Center, Ann Arbor, Michigan, United States
🇺🇸Sanford South University Medical Center, Fargo, North Dakota, United States
News
FDA Approves Elute's BonVie+: A Novel Resorbable Bone Void Filler Addressing Limitations of Current Options
Elute, Inc. has received FDA clearance for BonVie+, a calcium-salt resorbable bone void filler designed to overcome limitations of traditional bone cement and calcium sulfate-based alternatives.